Derek J Maetzold sold $750k of CSTL
Pres. & Chief Exec. Officer at CASTLE BIOSCIENCES INC. 26,123 shares at an average of $28.72, traded Dec 13, 2024, filed Dec 17, 2024.
Score components
- +25RoleCEO
- +22Trade size$750k at market
- +5Share of holdings soldSold 22% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.8%, 3m -27.2%, 6m -34.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001447362-24-000202, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 13, 2024 | SOpen-market sale Common Stock10b5-1 | -10,164 | $28.47 | $289k | 108,506 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold Descendants 2020 Trust10b5-1 | -381 | $28.47 | $11k | 73,225 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By Derek Maetzold 2020 Irrevocable Trust10b5-1 | -357 | $28.47 | $10k | 62,586 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk10b5-1 | -113 | $28.47 | $3,217 | 5,747 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold10b5-1 | -113 | $28.47 | $3,217 | 5,739 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold10b5-1 | -113 | $28.47 | $3,217 | 5,739 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold10b5-1 | -113 | $28.47 | $3,217 | 5,739 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stock10b5-1 | -3,321 | $29.16 | $97k | 105,185 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold Descendants 2020 Trust10b5-1 | -124 | $29.16 | $3,616 | 73,101 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By Derek Maetzold 2020 Irrevocable Trust10b5-1 | -117 | $29.16 | $3,412 | 62,469 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk10b5-1 | -37 | $29.16 | $1,079 | 5,710 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold10b5-1 | -37 | $29.16 | $1,079 | 5,702 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold10b5-1 | -37 | $29.16 | $1,079 | 5,702 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Common Stockindirect: By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold10b5-1 | -37 | $29.16 | $1,079 | 5,702 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -11,059 | $28.83 | $319k | 94,126 | Dec 17, 2024 |
Related signals
Other insiders at CASTLE BIOSCIENCES INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | CASTLE BIOSCIENCES INC | Derek J Maetzold Pres. & Chief Exec. Officer | $516k 14,496 shares | -49% | |
| 16Weak | CASTLE BIOSCIENCES INC | Kristen M Oelschlager Chief Operating Officer | $149k 4,153 shares | -24% | |
| 28Weak | CASTLE BIOSCIENCES INC | Tobin W Juvenal Chief Commercial Officer | $232k 6,577 shares | -11% | |
| 33Weak | CASTLE BIOSCIENCES INC | Derek J Maetzold Pres. & Chief Exec. Officer | $512k 14,496 shares | -48% | |
| 27Weak | CASTLE BIOSCIENCES INC | Tobin W Juvenal Chief Commercial Officer | $223k 6,600 shares | -10% | |
| 32Weak | CASTLE BIOSCIENCES INC | Derek J Maetzold Pres. & Chief Exec. Officer | $465k 14,518 shares | -48% | |
| 16Weak | CASTLE BIOSCIENCES INC | Kristen M Oelschlager Chief Operating Officer | $139k 4,152 shares | -24% | |
| 17Weak | CASTLE BIOSCIENCES INC | Tobin W Juvenal Chief Commercial Officer | $57k 1,730 shares | -3% | |
| 45Moderate | CASTLE BIOSCIENCES INC | Derek J Maetzold Pres. & Chief Exec. Officer | $616k 18,560 shares | -55% | |
| 29Weak | CASTLE BIOSCIENCES INC | Tobin W Juvenal Chief Commercial Officer | $317k 9,050 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.